Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Stopped early · Phase 2

Conditions studied: Non Hodgkin Lymphoma

In brief

Current therapies for Non-Hodgkin's Lymphoma provide limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Non-Hodgkin's Lymphoma. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Non-Hodgkin's Lymphoma.

Key facts

Study ID

NCT00003498

Run by

Burzynski Research Institute

People needed

5

Starts

1997-10-13

Expected to finish

2007-02-02

Last updated by the study team

2021-01-22

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Burzynski Clinic — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.